World Orphan Drug Congress USA 2019 is a global orphan drug conference and expo focusing on the most pressing challenges and opportunities to bring rare disease therapies to patients faster, and PPD, including Evidera, a PPD business unit, are highly focused on supporting companies in advancing orphan drugs for optimal regulatory and market access success. Margaret Vernon and Kevin Marsh with Evidera’s Patient-Centered Research team are presenting the following: Patient-Focused Rare Disease Clinical Trial Protocols: Patient-Centered Outcomes and Beyond.  Please stop by the PPD booth to say hello and speak with the presenters or any of the other experts in attendance.

Conference Website